.png)
A biotech quality management system (QMS) gives life sciences teams the controls they need to stay audit-ready and compliant with GxP, 21 CFR Part 11, and EU Annex 11.
At a minimum, a life sciences QMS should include controlled document management, Part 11-compliant electronic signatures, quality event management, audit and inspection readiness, training management, vendor qualification, automated workflows, reporting and alerts, validation and data integrity controls, and role-based access control.
The features below make up the core checklist most growing biotech and life sciences teams use when evaluating a QMS.
The 10 features every life sciences QMS should have:
- Controlled document management with version control
- Part 11-compliant electronic signatures
- Quality event management
- Audit and inspection readiness
- Training management
- Vendor and supplier qualification
- Automated workflows and approval routing
- Reporting, dashboards, and automated alerts
- Validation and data integrity controls
- Role-based access control and security
The rest of this guide explains what each feature does, why it matters in a regulated environment, and what to look for when you evaluate a system for your stage.
1. Controlled document management with version control
A life sciences QMS should be built on controlled document management, because nearly every quality process eventually points back to a document. SOPs, work instructions, policies, and records all need a single source of truth with enforced version control, so that the current effective version is always clear and superseded versions are retained for the record.
Look for a complete audit trail on every document action, including who created, edited, reviewed, and approved each version and when. This is the foundation auditors and inspectors expect, and it is what allows a CAPA or deviation to reference the exact controlled document that applies.
2. Part 11-compliant electronic signatures
Electronic signatures are a baseline requirement for any QMS operating under 21 CFR Part 11. Approvals on SOPs, quality events, and controlled documents need to be captured with compliant signatures that bind the signer, the meaning of the signature, and the timestamp to the record.
The cleanest setups offer this natively rather than relying on a separate signing tool added on top. Kivo, for example, includes Kivo Sign, a native Part 11-compliant e-signature capability, at no additional cost. A native signature flow keeps approvals inside the same system where the documents and quality records already live, which reduces handoffs and keeps the audit trail intact.
3. Quality event management
Quality event management is where a QMS earns its keep day to day. A strong system handles deviations, CAPAs, change control, and complaints in one place, with structured workflows that move each event from initiation through investigation, action, and closure.
Each quality event should link directly to the related documents, tasks, and owners, so the full history is connected rather than scattered across email and spreadsheets. That connection is what gives quality leaders a defensible record when an inspector asks how a specific issue was identified, investigated, and resolved.
4. Audit and inspection readiness
A QMS should make audits and inspections something you are always prepared for rather than something you scramble to assemble. That means internal audits, external audits, and vendor audits are all managed inside the system, with findings, responses, and corrective actions tracked to completion.
Inspection readiness comes from having documents, training records, quality events, and audit history connected and retrievable on demand. When everything traces back through a single audit trail, producing evidence during an FDA or notified body inspection becomes a matter of retrieval rather than reconstruction.
5. Training management
Training management ties your people to your procedures. A capable QMS lets you assign training based on role, link each training requirement directly to the relevant SOP or controlled document, and track completion across the team.
The most useful systems connect training to the document control system, so that when a procedure is revised, the people who need to be retrained are identified automatically. This closes a common compliance gap where staff continue working from an outdated version of a procedure.
6. Vendor and supplier qualification
Biotech teams rely heavily on vendors, CROs, and CDMOs, which makes supplier oversight a core QMS function. The system should support vendor qualification, ongoing vendor audits, and a maintained record of approved suppliers and their status.
Keeping vendor records inside the QMS, alongside the audits and quality events that involve them, gives you a complete picture of supplier performance and a ready answer when an inspector asks how you qualify and monitor the partners who touch your product.
7. Automated workflows and approval routing
Manual routing of reviews and approvals slows quality teams down and introduces room for error. A QMS should automate workflows so that documents and quality events move to the right reviewers and approvers in the right order, with status visible at every step.
Pre-structured and customizable templates help here, letting you standardize how common processes run while still adapting them to your organization. Automated routing also reduces the number of clicks and reminders required to keep work moving, which matters most for lean teams.
8. Reporting, dashboards, and automated alerts
Quality leaders need visibility into what is open, what is overdue, and what is trending. A QMS should provide reporting and dashboards that surface open quality events, upcoming training, pending approvals, and aging items at a glance.
Automated alerts and notifications keep work from stalling by prompting owners before deadlines pass. Intelligent reporting also supports management review and helps you spot recurring issues early, before they become inspection findings.
9. Validation and data integrity controls
In a regulated environment, the QMS itself has to be trustworthy. Validation matters, and the burden of validating a system can be significant for a small team. Look for software that is pre-validated and delivered with complete documentation, which reduces the validation work your organization has to take on for the platform itself. Keep in mind that customers retain validation responsibility for their own configured use, so the right question is how much of the lift the vendor removes.
Data integrity controls round this out. Strong audit trails, controlled access, and regular data integrity checks support the ALCOA principles that underpin GxP, 21 CFR Part 11, and EU Annex 11.
10. Role-based access control and security
A QMS holds sensitive, regulated content, so security and access control are non-negotiable. Role-based access control (RBAC) lets you define exactly who can view, edit, and approve content, with granular permissions that match your organization.
Supporting security features should include encryption of data in transit and at rest, detailed user permissions, and complete audit logging of system activity. Together these protect your records and demonstrate the control that auditors, inspectors, and future investors expect to see.
Two features that matter most for growing teams
The ten features above are the core. Two additional considerations tend to separate the systems that work for emerging and mid-size biotech from the ones that do not.
Built for lean teams without a dedicated IT function
Many emerging biotech companies run quality without a large IT department, so usability and a manageable rollout carry real weight. Modern, purpose-built systems can often be implemented in weeks rather than the many months legacy platforms require, though actual timelines vary by company size and the scope of your configuration and migration. An interface that feels familiar shortens the path to adoption and reduces the training burden on a small team.
A unified platform for all RegOps needs
Quality does not happen in isolation from documents, regulatory information, and clinical content. A unified platform keeps QMS connected to your DMS, RIM, and eTMF on a single system, so records, approvals, and audit trails flow across functions.
This is worth scrutinizing during evaluation. Several enterprise quality suites were assembled over time through acquisition, which can leave teams operating systems that were connected after the fact rather than designed together. Asking how the modules actually share data, and whether they live on one platform, helps you avoid that pattern.
How to evaluate QMS features for your stage
The right feature set depends on where your company is. An emerging biotech with a small quality team should weight usability, fast implementation, and a system that delivers compliance out of the box. A mid-size organization managing more vendors, more products, and more concurrent activities will lean harder on quality event volume, reporting depth, and the connection between QMS, DMS, RIM, and eTMF.
In both cases, the goal is the same: choose a system whose features keep you audit-ready, reduce manual effort, and scale with you rather than forcing a painful migration later.
Frequently asked questions
What is a QMS in biotech?
A QMS in biotech is a system that manages the documents, processes, and records a life sciences company uses to maintain quality and stay compliant with regulations such as GxP, 21 CFR Part 11, and EU Annex 11. It typically covers controlled documents, quality events, audits, training, and vendor oversight in one place. For a deeper definition, see our guide on what a QMS is in life sciences.
What is the difference between a QMS and a DMS?
A DMS (document management system) controls documents, versions, and approvals. A QMS includes document control and adds the quality processes built on top of it, such as deviations, CAPAs, change control, audits, training, and vendor management. In practice, a life sciences QMS is usually built on a compliant document management foundation.
Is a cloud-based QMS compliant with 21 CFR Part 11?
Yes, a cloud-based QMS can be fully compliant with 21 CFR Part 11 when it provides compliant electronic signatures, complete audit trails, controlled access, and validation. Cloud systems purpose-built for regulated life sciences environments are designed to meet Part 11 and EU Annex 11 requirements while removing the need to manage IT infrastructure.
Do small biotech companies need a full QMS?
Small biotech companies benefit from a QMS as soon as they need to demonstrate control over quality processes, which often comes well before commercialization. A right-sized, easy-to-implement system lets a small team stay audit-ready and prepared for partner and investor due diligence without the overhead of an enterprise deployment.
What QMS features are required for an FDA inspection?
For an FDA inspection, the features that matter most are controlled document management with audit trails, Part 11-compliant electronic signatures, quality event management for deviations and CAPAs, training records tied to procedures, and audit and inspection history. The common thread is traceability: being able to retrieve connected, time-stamped records that show how quality was maintained.
